305 filings
Page 6 of 16
8-K
fg7mb5d5 urscqcjto5
15 Jun 20
Entry into a Material Definitive Agreement
4:20pm
424B5
7hpgeiv
12 Jun 20
Prospectus supplement for primary offering
4:16pm
8-K
pgkxtimzxk
11 Jun 20
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
8:52am
8-K
dxmeb161f7gi
10 Jun 20
Catalent, Inc. Announces Public Offering of Common Stock
4:19pm
424B5
1q91nj k9
10 Jun 20
Prospectus supplement for primary offering
4:11pm
8-K
x2tqpuwg4 gw
5 May 20
Catalent, Inc. Reports Third Quarter Fiscal 2020 Results
7:32am
8-K
zimkovps
30 Apr 20
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
4:43pm
8-K
lr8kjko2kjs4g9s55m
3 Mar 20
Entry into a Material Definitive Agreement
4:16pm
8-K
r5w1i5
20 Feb 20
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028
4:28pm
8-K
zlgzwlo4
19 Feb 20
Catalent Announces Launch of Private Offering of €450 Million of Senior Unsecured Notes Due 2028
6:08am
8-K
lejcs3f0powqk294ceos
6 Feb 20
Entry into a Material Definitive Agreement
4:22pm
424B5
f7kj70kzl5dnsx9z6
5 Feb 20
Prospectus supplement for primary offering
12:00am
8-K
rphw wliru
4 Feb 20
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
12:00am
424B5
fto01
3 Feb 20
Prospectus supplement for primary offering
4:26pm
8-K
em9z1o
3 Feb 20
Catalent, Inc. Announces Public Offering of Common Stock
4:20pm
8-K
sqkpu
3 Feb 20
Catalent, Inc. Reports Second Quarter Fiscal 2020 Results
7:40am
8-K
5lm9b5 3p
5 Nov 19
Catalent, Inc. Reports First Quarter Fiscal 2020 Results
7:33am